ASN: Multicomponent Intervention Does Not Increase Steps Toward Kidney Transplant

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Nov. 8, 2023 -- A multicomponent intervention does not increase the rate of completed steps toward receiving a kidney transplant, according to a study published online Nov. 3 in JAMA Internal Medicine to coincide with Kidney Week, the annual meeting of the American Society of Nephrology, held from Nov. 2 to 5 in Philadelphia.

Amit X. Garg, M.D., Ph.D., from McMaster University in Hamilton, Ontario, Canada, and colleagues examined the effect of a multicomponent intervention designed to target barriers that prevent eligible patients from completing steps toward receipt of a kidney transplant in a two-arm trial involving all 26 chronic kidney disease (CKD) programs in Ontario. The intervention was composed of four components: administrative support to set up local quality improvement teams; educational resources; a story-sharing initiative for transplant recipients and living donors; and performance reports and oversight by administrative leaders. The primary outcome was the rate of completion of steps, with each patient able to complete four steps (referred to transplant center for evaluation; had a potential living donor contact a transplant center for evaluation; added to the deceased donor wait list; and received a transplant from a living or deceased donor).

The 26 CKD programs included 20,375 potentially transplant-eligible patients with advanced CKD (9,780 patients from 13 programs in the intervention group and 10,595 patients from 13 programs in the usual-care group). The researchers observed no significant difference between the groups in the step completion rate (24.8 versus 24.1 steps per 100 patient-years), despite evidence of intervention uptake.

"Improving access to transplantation remains a global priority that requires substantial effort," the authors write.

Several authors disclosed ties to Astellas Canada.

Abstract/Full Text

Editorial (subscription or payment may be required)

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords